Ellis Investment Partners’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-448
Closed -$6K 326
2022
Q3
$6K Hold
448
﹤0.01% 642
2022
Q2
$6K Hold
448
﹤0.01% 653
2022
Q1
$7K Hold
448
﹤0.01% 659
2021
Q4
$7K Hold
448
﹤0.01% 657
2021
Q3
$7K Hold
448
﹤0.01% 647
2021
Q2
$7K Hold
448
﹤0.01% 648
2021
Q1
$7K Hold
448
﹤0.01% 615
2020
Q4
$7K Hold
448
﹤0.01% 595
2020
Q3
$6K Hold
448
﹤0.01% 601
2020
Q2
$6K Hold
448
﹤0.01% 594
2020
Q1
$5K Hold
448
﹤0.01% 564
2019
Q4
$8K Hold
448
﹤0.01% 542
2019
Q3
$7K Hold
448
﹤0.01% 572
2019
Q2
$7K Buy
+448
New +$7.9K ﹤0.01% 553

Other funds holding DIAX

Ellis Investment Partners's DIAX Position: Q4 2022 in Review

Ellis Investment Partners sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q4 2022, closing a stake of 448 shares — an estimated $6K sold.

Ellis Investment Partners first reported a position in DIAX in Q2 2019 and held it in 14 quarters. The position peaked at $8K in Q4 2019. 80 funds tracked by Wall St. Rank hold DIAX as of Q4 2022.

  • Ellis Investment Partners reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 448 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q4 2022, an estimated $6K.
  • Ellis Investment Partners first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q2 2019 and held it in 14 quarters.
  • Ellis Investment Partners's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $8K in Q4 2019.
  • 80 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.